Literature DB >> 31473280

Voltage-Gated Sodium Channels Are Involved in Cognitive Impairments in Parkinson's Disease- like Rats.

Ziyi Wang1, Yuying Lin1, Weitang Liu1, Ping Kuang1, Wenwen Lao1, Yonghua Ji1, Hongyan Zhu2.   

Abstract

Cognitive impairment is one of the common non-motor symptoms in Parkinson's disease (PD). The hippocampus is a critical structure for learning and memory processes. The abnormal synaptic plasticity in the hippocampus is suggested to be associated with cognitive dysfunction in PD. Voltage gated sodium channels (VGSCs) are key molecules involved in synaptic transmission in the nervous system. Here, the expression patterns of VGSC subtypes Nav1.1, Nav1.3, Nav1.6 in the hippocampus of 6-hydroxydopamine (6-OHDA) lesioned rats were investigated at different time points after 6-OHDA injection. The results showed that the expression of Nav1.1 was remarkably increased in reactive astrocytes at 28days, whereas was sharply reduced at 49days after 6-OHDA injection. However, the expression of Nav1.6 was not different from the control hippocampus at 28days, but was abundantly increased in neurons of the contralateral and ipsilateral hippocampus at 49days after 6-OHDA injection. Moreover, Nav1.3, a subtype predominantly expressed at embryonic stage, was scatteredly re-expressed in neurons of the CA area in the contralateral and ipsilateral hippocampus at 49days after 6-OHDA injection. Furthermore, spatial learning and memory in 6-OHDA lesioned rats were effectively improved by acute treatment with a VGSCs blocker, phenytoin. These findings suggested that VGSCs may play an important role in the genesis of cognitive deficits in PD.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Parkinson's disease; cognitive dysfunction; hippocampus; voltage gated sodium channels

Year:  2019        PMID: 31473280     DOI: 10.1016/j.neuroscience.2019.08.024

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  3 in total

1.  Brain injury and inflammation genes common to a number of neurological diseases and the genes involved in the genesis of GABAnergic neurons are altered in monoamine oxidase B knockout mice.

Authors:  Kevin Chen; Tamara Palagashvili; W Hsu; Yibu Chen; Boris Tabakoff; Frank Hong; Abigail T Shih; Jean C Shih
Journal:  Brain Res       Date:  2021-11-12       Impact factor: 3.252

Review 2.  Experimental Models of Cognitive Impairment for Use in Parkinson's Disease Research: The Distance Between Reality and Ideal.

Authors:  Yaohua Fan; Jiajun Han; Lijun Zhao; Chunxiao Wu; Peipei Wu; Zifeng Huang; Xiaoqian Hao; YiChun Ji; Dongfeng Chen; Meiling Zhu
Journal:  Front Aging Neurosci       Date:  2021-11-29       Impact factor: 5.750

Review 3.  The Role of NEDD4 E3 Ubiquitin-Protein Ligases in Parkinson's Disease.

Authors:  James A Conway; Grant Kinsman; Edgar R Kramer
Journal:  Genes (Basel)       Date:  2022-03-14       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.